DNA Based Therapeutics

COMBINED SYNOPSIS/SOLICITATION This combined synopsis/solicitation is expected to result in the award of a firm-fixed-price contract for a DNA Based Therapeutics as described under the requirements section of this combined synopsis/solicitation and accompanying requirements attachment. This combined synopsis/solicitation is prepared in accordance with the format in the Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This solicitation incorporates FAR provisions and clauses in effect through Federal Acquisition Circular (FAC) 2005-101, effective 20 Jul 2018; Defense Federal Acquisition Regulation Supplement (DFARS) Publication Notice (DPN) 20180629, effective 20 June 2018; and Air Force Federal Acquisition Regulation Supplement (AFFARS) Air Force Acquisition Circular (AFAC) 2018-0525, effective 25 May 2018. This announcement constitutes the only combined synopsis/solicitation; proposals are being requested and a written solicitation will not be issued. An award, if any, will be made to the responsible Offeror who submits a proposal that: 1. Conforms to the requirements of the combined synopsis/solicitation. 2. Receives a rating of "Acceptable" on the Technical Capability evaluation factor. 3. Contains the lowest total evaluated price (TEP), provided that the TEP is not unbalanced and is fair and reasonable. The combined synopsis/solicitation number for this requirement is FA8601-18-R-0066-1 and is hereby issued as a Request for Proposal (RFP) using FAR Part 12, Acquisition of Commercial Items and FAR Part 13, Simplified Acquisition Procedures. The associated North American Industrial Classification System (NAICS) code is 334519 with a business size standard of 500 employees. NAICS Code: 334519 - Other Measuring and Controlling Device Management Business Size Standard: 500 Employees The TEP consists of these Contract Line Items Number (CLIN), which should be structured as follows: CLIN 0001- CLIN 0021 Acceptable means of Submission: All submissions must be submitted electronically to the following email address clarence.taylor.2@us.af.mil & jessica.stamper.2@us.af.mil by 1:00 P.M. EST on 02 August 2018. Any correspondence sent via e-mail must contain the subject line "FA8601-18-R-0066-1, DNA Based Therapeutics." The entire proposal must be contained in a single e-mail, unless otherwise approved, and must not exceed 5 megabytes, including attachments. E-mails with compressed files will not be accepted. Note that e-mail filters at Wright-Patterson Air Force Base are designed to filter e-mails without subject lines or with suspicious subject lines or contents (i.e., .exe or .zip files). Therefore, if the specified subject line is not included, the e-mail may not get through the e-mail filters. Also be advised that .zip or .exe files are not allowable attachments and may be deleted by the email filters at Wright-Patterson. If sending attachments with email, ensure only .pdf, .doc, .docx, .xls or .xlsx documents are sent. The email filter may delete any other form of attachments. Submittal of proposals in response to this combined synopsis/solicitation constitutes agreement by the Offeror to all terms & conditions contained herein, which will also be the terms & conditions of any resulting contract. It is the Offerors responsibility to be familiar with the applicable clauses and provisions. Clauses and provisions in full text may be accessed via the Internet website http://farsite.hill.af.mil. The Government reserves the right to award without discussions or make no award depending upon the quality, price fairness, and price reasonableness of the proposals received. Delivery Schedule: 15 days ADC Delivery Destination: 711th HPW/OML Attn: SSgt Brittany Andrews 2510 Fifth Street (Area B) Wright Patterson AFB, OH 45433 Delivery Type: FOB Destination (As defined in FAR 2.101-Definitions, the seller or consignor is responsible for the cost of shipping and risk of loss.) Inspection and Acceptance: Both inspection and acceptance will be by the Government at Destination. Requirement: The United States Air Force School of Aerospace Medicine Applied Technology and Genomics Division (USAFSAM /FHT) is seeking to procure vendor supported reagents, assays and other supplies necessary to perform analysis of infectious diseases. The FHT projects support the mission at the USAFSAM by providing continual evaluation, validation, and transition assistance with new off-the-shelf technologies and genomics technologies. The evaluation of improved methods will help fill in critical gaps in troop protection, diagnostics, epidemiology and preventative medicine. FHT's research is to support the medical screening of Airmen throughout their careers by developing surveillance assays for more than 30,000 annual accessions. The work performed herein is intended to develop therapeutic interventions for infectious diseases triggered by the pathogen itself. Supply of the DNA Based Therapeutics are to be provided in accordance with Statement of Work dated 23 April 2018, (Attachment 1). The anticipated award is Firm-Fixed-Price LPTA. The Government will award a contract resulting from this combined synopsis/solicitation to the responsible Offeror whose offer conforms to the combined synopsis/solicitation and is most advantageous to the Government, price and other factors considered. Technical Capability and Price will be used to evaluate all offers. The proposals may be in any format but MUST include: 1. Proposing company's name, address, DUNS number, Cage Code, and TIN. 2. Point of contact's name, phone, and email. 3. Proposal number & date. 4. Timeframe that the proposal is valid. 5. Individual item price. 6. Total price (Net 30), No Progress Payments. 7. Shipping (FOB Destination). 8. Delivery Schedule. 9. Completed copy of representations and certifications (Attachment 2) Important Notice to Contractors: Proposals MUST also contain a complete description of items offered and any technical manuals or literature to clearly show that the items meet or exceed the requirements outlined in the Statement of Work (Attachment 1). The Contracting Officer will review proposal based on the factors listed in this combined synopsis/solicitation and the information furnished by the Offeror. Before price is considered, the proposal must meet the technical specifications of this combined synopsis/solicitation. Important Notice to Contractors: All prospective awardees are required to register at the System for Award Management (SAM) and to maintain active registration during the life of the contract. SAM can be accessed at https://www.sam.gov. Any award resulting from this combined synopsis/solicitation will include DFARS Clause 252.232-7003, Electronic Submission of Payment Requests. Section 1008 of the National Defense Authorization Act of Fiscal Year 2001 requires any claims for payment (invoices) under DoD contract to be submitted in electronic form. Wide Area Workflow - Receipt and Acceptance (WAWF - RA) is the DoD system of choice for implementing this statutory requirement. Use of the basic system is at no cost to the contractor. Contractors must complete vendor training, which is also available at no cost at http://www.wawftraining.com. Prior to submitting invoices in the production system, contractors must register for an account at http://wawf.eb.mil/. Representations and Certifications: Offerors shall complete and submit the following representations and certifications with the offeror's price proposal/quote, unless the offeror has completed the representations and certifications online in the System for Award Management (http://www.sam.gov), and the existing online representations and certifications are current, accurate and complete: FAR 52.212-3-Offeror Representations and Certifications-Commercial Items (Jan 2017) with its Alternate I (Oct 2014) FAR 52.222-22 -- Previous Contracts and Compliance Reports. (Feb 1999) FAR 52.222-25 -- Affirmative Action Compliance. (Apr 1984) FAR 52.209-11 - Representation by corporations regarding delinquent tax Liability or a felony conviction under any federal law (Feb 2016) ADDITIONAL INSTRUCTIONS TO OFFERORS Proposal Content: Proposals shall consist of two separate parts, a technical proposal and a price proposal. Length of the proposal shall not exceed ten (10) typed pages. Proposal Detail: The proposal shall be clear, concise, and shall include sufficient detail for effective evaluation and for substantiating the validity of stated claims. The proposal should not simply rephrase or restate the Government's requirements, but rather shall provide convincing rationale to address how the offeror intends to meet the listed requirements. Offerors shall assume that the Government has no prior knowledge of their facilities and experience, and will base its evaluation on the information presented in the offer submitted. Embellishments Not Desired: Elaborate brochures or documentation, binding, detailed artwork or other embellishments are unnecessary and are not desired. Technical Proposal: Describe how the offeror will provide for the DNA Based Therapeutics as described in the SOW. CLIN 0001-0021 and Provisions and Clauses can be found in Attachment 2. Attachments: 1. Statement of Work 2. CLIN, Provisions and Clauses Please direct all questions to clarence.taylor.2@us.af.mil & jessica.stamper.2@us.af.mil